Ghent University Academic Bibliography

Your filters: cql: author="Berghen, Charlien" or (type any "bookEditor issueEditor" and editor="Berghen, Charlien")

Add to list
- Journal Article
- A1
- open access
Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints

Flor Verghote (UGent) , Elke Rammant (UGent) , Piet Dirix, Charles Van Praet (UGent) , Charlien Berghen, Sara Junius, Nick Liefhooghe, Leen Noé, Piet Ost (UGent) , Karel Decaestecker (UGent) , et al.

(2025) EUROPEAN UROLOGY FOCUS. 11(4). p.595-602
Add to list
- Conference Paper
- C3
Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)

Flor Verghote (UGent) , Piet Dirix, Charles Van Praet (UGent) , Charlien Berghen, Ben Vanneste (UGent) , Sara Junius, Nick Liefhooghe, Leen Noé, Gert De Meerleer, Piet Ost (UGent) , et al.

(2024) RADIOTHERAPY AND ONCOLOGY. In Radiotherapy and Oncology 194(Supplement 1). p.S2308-S2311
Add to list
- Journal Article
- A1
- open access
Evaluating the impact of prostate only versus pelvic radiotherapy for pathological node-positive prostate cancer : first results from the multicenter phase 3 PROPER trial

Valerie Fonteyne (UGent) , Charles Van Praet (UGent) , Piet Ost (UGent) , Siska Van Bruwaene, Nick Liefhooghe, Charlien Berghen, Gert De Meerleer, Ben Vanneste (UGent) , Caroline Verbaeys, Sofie Verbeke, et al.

(2023) EUROPEAN UROLOGY FOCUS. 9(2). p.317-324
Add to list
- Journal Article
- A1
- open access
International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy : update from an IBIS workgroup

Flor Verghote (UGent) , Paul Sargos, John P. Christodouleas, Vedang Murthy, Brian C. Baumann, Piet Dirix, Charlien Berghen, Leen Paelinck (UGent) , Tom Vercauteren (UGent) and Valerie Fonteyne (UGent)

(2022) PRACTICAL RADIATION ONCOLOGY. 12(6). p.524-532
Add to list
Progression-directed therapy for oligoprogression in castration-refractory prostate cancer

Charlien Berghen, Steven Joniau, Piet Ost (UGent) , Kenneth Poels, Wouter Everaerts, Karel Decaestecker (UGent) , Karin Haustermans, Gaëtan Devos and Gert De Meerleer

(2021) EUROPEAN UROLOGY ONCOLOGY. 4(2). p.305-309
Add to list
- Journal Article
- A1
- open access
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Flor Verghote (UGent) , Lindsay Poppe (UGent) , Sofie Verbeke (UGent) , Piet Dirix, Maarten Albersen, Gert De Meerleer, Charlien Berghen, Piet Ost (UGent) , Geert Villeirs (UGent) , Pieter De Visschere (UGent) , et al.

(2021) BMC CANCER. 21(1).
Add to list
Metastasectomy for visceral and skeletal oligorecurrent prostate cancer

Antonino Battaglia, Gaetan Devos, Karel Decaestecker (UGent) , Manuel Witters, Lisa Moris, Thomas Van den Broeck, Charlien Berghen, Wouter Everaerts, Maarten Albersen, Arman Tsaturyan, et al.

(2019) WORLD JOURNAL OF UROLOGY. 37(8). p.1543-1549
Add to list
Readressing the rationale of irradiation in stage I seminoma guidelines : a critical essay

Charlien Berghen, Maarten Albersen, Pierre Blanchard, Alberto Bossi, Alberto Briganti, Cesare Cozzarini, Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , Karin Haustermans, Steven Joniau, et al.

(2019) BJU INTERNATIONAL. 124(1). p.35-39

Academic Bibliography

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints

Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)

Evaluating the impact of prostate only versus pelvic radiotherapy for pathological node-positive prostate cancer : first results from the multicenter phase 3 PROPER trial

International consensus guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy : update from an IBIS workgroup

Progression-directed therapy for oligoprogression in castration-refractory prostate cancer

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Metastasectomy for visceral and skeletal oligorecurrent prostate cancer

Readressing the rationale of irradiation in stage I seminoma guidelines : a critical essay

Contents

Support

Contact